LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
TIETUO MACHINERY
873706
5
Ji Yao Holding Group
300108
US Stock MarketDetailed Quotes
ABUS Arbutus Biopharma
- 3.370
- -0.070-2.03%
Close Feb 27 16:00 ET
- 3.370
- 0.0000.00%
Post 20:01 ET
638.59MMarket Cap-7.84P/E (TTM)
3.500High3.270Low1.39MVolume3.500Open3.440Pre Close4.68MTurnover1.04%Turnover RatioLossP/E (Static)189.49MShares4.72552wk High5.98P/B452.66MFloat Cap2.30052wk Low--Dividend TTM134.32MShs Float31.480Historical High--Div YieldTTM6.69%Amplitude0.821Historical Low3.367Avg Price1Lot Size
Arbutus Biopharma Key Stats
EPS
According to the latest financial report of Arbutus Biopharma, the latest earnings per share (TTM) for the company is -0.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Arbutus Biopharma's free cash flow? The latest report shows it as -20.74M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Arbutus Biopharma shows that the company's current ratio is 7.02, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Arbutus Biopharma, the quick ratio is 6.84, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Arbutus Biopharma? The latest ROE figure is -17.19%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Arbutus Biopharma, the total asset return on investment (ROA) is -13.12%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Arbutus Biopharma's latest financial report to see how their gross margin is doing - currently at -5.30%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Arbutus Biopharma, the net profit margin is -1.47K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call